Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality ImprovementRelease Date:Quality Improvement Oncology Kazakhstan Implementing Germline and Somatic Testing for Precision Medicine in Community-Based Prostate Cancer CareEducation Oncology USA Improving Shared Decision Making in Hemophilia: Visiting Professorship ProgramRelease Date:Partner: Hemostasis & Thrombosis Research Society (HTRS)Education Rare Disease USA Improving Metastatic Prostate Cancer (mPCa) Care Through Innovative StrategiesRelease Date:Quality Improvement Oncology All Novel Therapies for Relapsed/Refractory Large B-Cell Lymphoma in Community Oncology PracticeRelease Date:Education Oncology USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology China, France, Germany, Italy, Japan, Spain, Turkey, United Kingdom Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding DisordersRelease Date:Research Rare Disease All Biochemical and Molecular Characterization of Marstacimab and TFPI PathwaysRelease Date:Research Rare Disease Brazil, China, Germany, Italy, Japan, Korea, Netherlands, Saudi Arabia, Spain, Turkey, USA, United Kingdom Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptomsRelease Date:Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence ApproachRelease Date:Research Inflammation & Immunology USA Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUCEducation Oncology USA Advancing Genomic Competence and Patient Centered Care in Metastatic Breast CancerRelease Date:Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction ManagementRelease Date:Research Internal Medicine Australia, Canada, China, Germany, Greece, Japan, Korea, Taiwan Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-positRelease Date:Education Oncology United States Minor Outlying I OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic MalignanciesRelease Date:Quality Improvement Oncology China Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory OutcomeRelease Date:Education Vaccines USA Title Grant Type Focus Area Country Application Due Date Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career InvestigatorsRelease Date:Research Inflammation & Immunology USA Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Established InvestigatorsRelease Date:Research Inflammation & Immunology USA 2022 Rheumatology Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Innovative Digital Health Projects in OncologyRelease Date:Quality Improvement Oncology Italy BRAF V600-mutant colorectal cancer: disease education and therapy managementEducation Oncology USA Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM in CanadaRelease Date:Quality Improvement Rare Disease Canada Heart Failure and Cardiomyopathy Leading to Differential Diagnoses of Cardiac AmyloidosisRelease Date:Education Rare Disease Japan Establish a System to Refer Patients with Suspected CardiomyopathyRelease Date:Quality Improvement Rare Disease Japan Improving the care of patients living with metastatic breast cancer (mBC)Quality Improvement Oncology Canada Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access DisparitiesQuality Improvement Hospital All Global ATTR Amyloidosis ResearchRelease Date:Research Rare Disease All Promotion of Smoking Cessation Treatment in General PracticeRelease Date:Education Internal Medicine Japan Improvement of Treatment Environment for Advanced / Recurrent Breast CancerRelease Date:Education Oncology Japan Improving RCC Patient OutcomesRelease Date:Education Oncology France, Germany, Italy, Spain, USA, United Kingdom Biomarker Testing / Lung CancerRelease Date:Education Oncology Japan Employment support / Lung CancerRelease Date:Education Oncology Japan Immunotherapy in Urothelial CarcinomaEducation Oncology All Pre-clinical and Translational Research in Multiple MyelomaRelease Date:Research Oncology Italy PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA Knowledge Gaps in Updated Adult Pneumococcal Immunization RecommendationsRelease Date:Education Vaccines USA Establishment of Hospital-Clinic Collaboration Model for Undiagnosed Rheumatic DiseasesRelease Date:Partner: The Japan College of RheumatologyQuality Improvement Inflammation & Immunology Japan COVID-19 Vaccine Development for LMICsRelease Date:Research Vaccines All Quality Improvement Grants to Support Development of Cardiac Amyloid CentersRelease Date:Quality Improvement Rare Disease USA Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Closing Knowledge Gaps in Transthyretin Cardiomyopathy (ATTR-CM)Release Date:Education Rare Disease USA Hereditary Transthyretin Amyloidosis Research in ChinaRelease Date:Research Rare Disease China Advances in Immuno-Oncology Therapy in Urothelial CancerRelease Date:Education Oncology Japan RWD in the management of MDR BacteRial severe InfEctions and invasive Fungal disease, ITalian experiencesRelease Date:Research Hospital Italy Improving Treatment Environment for Acute LeukemiaRelease Date:Education Oncology Japan Transthyretin Amyloid Cardiomyopathy (ATTR-CM) ResearchRelease Date:Research Rare Disease USA Transthyretin Cardiac Amyloidosis Fellowship - United StatesRelease Date:Fellowship Rare Disease USA Applying Patient-Reported Outcomes in Oncology Patient Care Using Quality Improvement and Implementation Science StrategiesQuality Improvement Oncology USA Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and CaregiversRelease Date:Research Inflammation & Immunology Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, Finland, France, Germany, Greece, Ireland, Israel, Italy, Japan, Korea, Netherlands, Norway, Poland, Portugal, Romania, Russia, Slovakia (Slovak Republic), Spain, Sweden, Switzerland, Turkey, United Kingdom Understanding and Mitigating Cardiovascular Risk in Patients with Prostate CancerQuality Improvement Oncology USA Cardiac Amyloidosis Mentor mATTch pRogramEducation Rare Disease USA Knowledge Gaps in Testing, Diagnosis and Treatment of COVID-19Release Date:Education Hospital USA Real World Experience with Biosimilar Medicines in OncologyRelease Date:Education Oncology All Education of Healthcare Professionals to Provide Appropriate Medical Care for IBD PatientsRelease Date:Education Inflammation & Immunology Japan Improving COVID-19 Outpatient Management (Emerging market countries listed in Geographic Scope)Release Date:Quality Improvement Hospital All Quality Improvement in Pediatric Endocrinology fieldsRelease Date:Partner: The Japanese Society for Pediatric EndocrinologyQuality Improvement Rare Disease Japan COVID-19 Patient Awareness (United States and Europe)Release Date:Education Hospital All Improving Cytogenetic Testing & Treatment Guidance in Adult AMLRelease Date:Quality Improvement Oncology Canada Acromegaly Research- United StatesRelease Date:Research Rare Disease USA Best Practices in the Clinical Management of Patients with BRAF-mutant Metastatic MelanomaRelease Date:Education Oncology USA Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Innovative Solutions in Atopic Dermatitis and Alopecia Areata Management 2022 I&I IT INNOVA-DERMARelease Date:Quality Improvement Inflammation & Immunology Italy ASTRO-Myovant Sciences-Pfizer Alliance New Combination Therapy ChallengeResearch Oncology USA Early Diagnosis of Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)Release Date:Research Hospital All